跳至主要内容
临床试验/NCT05502874
NCT05502874尚未招募不适用

Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,600
试验地点
1
主要终点
Early neurological deterioration (END)

研究概览

简要总结

This multicenter observational study will explore the risk factors of early neurological deterioration(END) in patients with primary and to investigate the association between END and outcome.

详细描述

Neurological deterioration affects approximately one-third of patients with primary intracerebral hemorrhage (ICH) and increases the risk of death and dependency. However, the risk factors of early neurological deterioration (END), such as biochemical parameters, neuroimaging, and systemic complications, are not well documented in primary ICH, and the effective predictors of END is unknown.

This multicenter observational study aims to seek out the risk factors of END in patients with primary ICH and to investigate the association between END and outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of primary intracerebral hemorrhage

排除标准

  • Patients with secondary
  • Undergo surgical evacuation of hematoma;
  • Presenting contraindications or refusal to MRI
  • Is pregnant
  • Patients refuse to be followed up for any reasons.

结局指标

主要结局

Early neurological deterioration (END)

时间窗: 48 hours after admission

END is defined as an increase in the total NIHSS score of ≥ 4 points within the first 48 h after admission

次要结局

  • The quality of life(90 days, 1 year, 2 years after admission)
  • Late neurological deterioration (LND)(7 days)
  • Cognitive function(90 days, 1 year, 2 years after admission)
  • Functional outcome(90 days, 1 year, 2 years after admission)
  • Hematoma expansion(24 hours after admission)
  • Depression status(90 days, 1 year, 2 years after admission)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验